Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection.
Lasmar, Marcus Faria
Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection. [electronic resource] - BMC nephrology 08 2019 - 314 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2369
10.1186/s12882-019-1497-5 doi
Adult
Age Factors
Antilymphocyte Serum--therapeutic use
Cadaver
Cyclosporine--adverse effects
Female
Graft Rejection--immunology
Graft Survival--immunology
Humans
Immunosuppressive Agents--adverse effects
Immunotherapy--methods
Kidney Transplantation
Living Donors--statistics & numerical data
Maintenance Chemotherapy--methods
Male
Methylprednisolone--adverse effects
Mycophenolic Acid--therapeutic use
Retrospective Studies
Risk
Sex Factors
Sirolimus--therapeutic use
Survival Rate
T-Lymphocytes
Tacrolimus--adverse effects
Time Factors
Treatment Outcome
Effects of immunotherapy induction on outcome and graft survival of kidney-transplanted patients with different immunological risk of rejection. [electronic resource] - BMC nephrology 08 2019 - 314 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2369
10.1186/s12882-019-1497-5 doi
Adult
Age Factors
Antilymphocyte Serum--therapeutic use
Cadaver
Cyclosporine--adverse effects
Female
Graft Rejection--immunology
Graft Survival--immunology
Humans
Immunosuppressive Agents--adverse effects
Immunotherapy--methods
Kidney Transplantation
Living Donors--statistics & numerical data
Maintenance Chemotherapy--methods
Male
Methylprednisolone--adverse effects
Mycophenolic Acid--therapeutic use
Retrospective Studies
Risk
Sex Factors
Sirolimus--therapeutic use
Survival Rate
T-Lymphocytes
Tacrolimus--adverse effects
Time Factors
Treatment Outcome